COPH.D Stock Overview Engages in the development, cultivation, and distribution of recreational and medical cannabis products in Europe, Canada, Australia, and the Asia Pacific. More details
Risk Analysis + 1 more risk
See All Risk Checks {"enabled":false,"variant":{"name":"disabled","enabled":false},"ready":false,"error":null}
Capture your thoughts, links and company narrative
Melodiol Global Health Limited Competitors Price History & Performance
Summary of share price highs, lows and changes for Melodiol Global Health Historical stock prices Current Share Price AU$0.12 52 Week High AU$283.98 52 Week Low AU$0.012 Beta 2.53 1 Month Change 0% 3 Month Change n/a 1 Year Change -98.62% 3 Year Change -99.86% 5 Year Change -99.95% Change since IPO -99.95%
Recent News & Updates Melodiol Global Health Limited has completed a Follow-on Equity Offering in the amount of AUD 3 million. Jun 05
Melodiol Global Health Limited has filed a Follow-on Equity Offering in the amount of AUD 3 million. May 03
Melodiol Global Health Limited, Annual General Meeting, May 31, 2024 Mar 28 Melodiol Global Health Limited has filed a Follow-on Equity Offering in the amount of AUD 6 million. Feb 22
Melodiol Global Health Limited Option Expiring 13 November 2028 Deferred Settlement Deleted from OTC Equity Feb 07 Melodiol Global Health Limited has completed a Follow-on Equity Offering in the amount of AUD 0.215 million. Jan 16
See more updates Melodiol Global Health Limited has completed a Follow-on Equity Offering in the amount of AUD 3 million. Jun 05
Melodiol Global Health Limited has filed a Follow-on Equity Offering in the amount of AUD 3 million. May 03
Melodiol Global Health Limited, Annual General Meeting, May 31, 2024 Mar 28 Melodiol Global Health Limited has filed a Follow-on Equity Offering in the amount of AUD 6 million. Feb 22
Melodiol Global Health Limited Option Expiring 13 November 2028 Deferred Settlement Deleted from OTC Equity Feb 07 Melodiol Global Health Limited has completed a Follow-on Equity Offering in the amount of AUD 0.215 million. Jan 16
Melodiol Global Health Limited Announces Resignation of Erlyn Dawson as Joint Company Secretary Dec 22 Melodiol Global Health Limited has completed a Follow-on Equity Offering in the amount of AUD 0.231808 million. Dec 07
Melodiol Global Health Limited has completed a Follow-on Equity Offering in the amount of AUD 1.022261 million. Nov 29
Melodiol Global Health Limited has completed a Follow-on Equity Offering in the amount of AUD 1.022261 million. Nov 28
Melodiol Global Health Limited has filed a Follow-on Equity Offering in the amount of AUD 1.010906 million. Nov 14
Melodiol Global Health Limited has completed a Follow-on Equity Offering in the amount of AUD 0.574725 million. Aug 14
Panacea Life Sciences Holdings, Inc. (OTCPK:PLSH) entered into a non-binding LOI to acquire Sierra Sages Herbs, LLC and Halucenex Life Sciences Inc. for $20 million. Aug 03
Creso Pharma Limited (ASX:CPH) entered into a binding letter of intent to acquire Abby & Finn, LLC for $2.5 million. Jan 27
Creso Pharma Limited Announces Board Changes Dec 01
Creso Pharma Limited Announces Director Appointments Oct 15
Creso Pharma Limited Announces Board Changes Oct 10
Sierra Sage Secures USD 214,000 Purchase Order from Walmart Sep 02
Creso Pharma Limited (ASX:CPH) signed a non-binding, non-exclusive heads of agreement to acquire Dr Pickles Pty Ltd. May 23
Creso Pharma Limited, Annual General Meeting, May 31, 2022 Apr 13 Creso Pharma Limited announced that it expects to receive AUD 5 million in funding Feb 25
Creso Pharma to Develop New Hemp-Based Lozenge Product Feb 11
Creso Pharma Limited Launches New E-Commerce Channels Sep 19
Creso Pharma Limited (ASX:CPH) completed the acquisition of Halucenex Life Sciences Inc. Jul 15
Creso Pharma Limited Launches New Product May 18
Creso Pharma Limited (ASX:CPH) entered into an agreement to acquire Halucenex Life Sciences Inc. CAD 10 million. Mar 15
Creso Pharma Limited Signs Non-Binding Letter of Intent with ImpACTIVE Holdings Ltd Mar 10
Creso Pharma Limited Executes A Non-Binding Letter of Intent with Ceres Natural Remedies Mar 01
Creso Pharma Limited Revises Earnings Guidance for the Fiscal Year 2021 Feb 26
Creso Pharma Limited Announces Distribution Agreement with Route2 Pharm Pvt Ltd Feb 16 CBD Oil legal in Australia - Creso Pharma Limited to benefit
Creso Pharma Limited has announced a Derivatives Offering in the amount of AUD 9.523042 million. Jan 22
Creso Pharma Limited Secures New Purchase Order for its Leading Range of Animal Health Products Anibidiol Jan 20
Creso Pharma Limited Secures First Purchase Order for Animal Health Products in LATAM Dec 21
Creso Pharma Limited Announces TGA Decision to Reschedule CBD Dec 16
Creso Pharma Limited Receives New Purchase Orders for Anibidiol® Products Dec 04
Creso Pharma Limited Receives Second Purchase Order from Pharma Dynamics, South Africa Oct 13
Creso Pharma Limited announced that it expects to receive AUD 8.992531 million in funding Oct 07
Creso Pharma Limited Announces CEO, Miri Halperin Wernli to Take Role of Technology, Innovation and Distribution Head Aug 17 Shareholder Returns COPH.D US Pharmaceuticals US Market 7D 0% 1.2% 0.2% 1Y -98.6% 1.4% 23.1%
See full shareholder returns
Return vs Market: COPH.D underperformed the US Market which returned 20.7% over the past year.
Price Volatility Is COPH.D's price volatile compared to industry and market? COPH.D volatility COPH.D Average Weekly Movement n/a Pharmaceuticals Industry Average Movement 10.1% Market Average Movement 5.9% 10% most volatile stocks in US Market 18.3% 10% least volatile stocks in US Market 3.0%
Stable Share Price: COPH.D has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine COPH.D's volatility change over the past year.
About the Company Melodiol Global Health Limited engages in the development, cultivation, and distribution of recreational and medical cannabis products in Europe, Canada, Australia, and the Asia Pacific. It is involved in the development and commercialisation of nutraceutical products; and medical supplies business. The company was formerly known as Creso Pharma Limited and changed its name to Melodiol Global Health Limited in June 2023.
Show more Melodiol Global Health Limited Fundamentals Summary How do Melodiol Global Health's earnings and revenue compare to its market cap? COPH.D fundamental statistics Market cap US$72.91k Earnings (TTM ) -US$23.69m Revenue (TTM ) US$12.62m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) COPH.D income statement (TTM ) Revenue AU$18.92m Cost of Revenue AU$18.10m Gross Profit AU$817.00k Other Expenses AU$36.34m Earnings -AU$35.52m
Last Reported Earnings
Dec 31, 2023
Earnings per share (EPS) -0.97 Gross Margin 4.32% Net Profit Margin -187.73% Debt/Equity Ratio -232.0%
How did COPH.D perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/06/29 22:21 End of Day Share Price 2024/04/01 00:00 Earnings 2023/12/31 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github .
Analyst Sources Melodiol Global Health Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
